Evidence map›Paper›PMID 41799786›Full record

ArticleJAAD international2026

Clinical utility of comprehensive genomic profiling in 175 Japanese patients with advanced skin malignancies refractory to standard therapies.

Yumi Kambayashi, Taku Fujimura, Hiroshi Kato, Soichiro Kado, Takeo Maekawa, Fumitaka Ono, Takamichi Ito, Megumi Aoki, Shigeto Matsushita, Azusa Miyashita and 6 more

Abstract read
In one paragraph

Article in JAAD international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Yumi KambayashiDepartment of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Taku FujimuraDepartment of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Hiroshi KatoDepartment of Geriatric and Environmental Dermatology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Soichiro KadoDepartment of Dermatology, Jichi Medical University, Shimono, Japan.
Takeo MaekawaDepartment of Dermatology, Jichi Medical University, Shimono, Japan.
Fumitaka OnoDepartment of Dermatology, Kyushu University, Fukuoka, Japan.
Takamichi ItoDepartment of Dermatology, Kyushu University, Fukuoka, Japan.
Megumi AokiDepartment of Dermato-Oncology, NHO Kagoshima Medical Center, Kagoshima, Japan.
Shigeto MatsushitaDepartment of Dermato-Oncology, NHO Kagoshima Medical Center, Kagoshima, Japan.
Azusa MiyashitaDepartment of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Satoshi FukushimaDepartment of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Daiki RokunoheDepartment of Dermatology, Hirosaki University, Hirosaki, Japan.
Emi YamazakiDepartment of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Manami Takahashi-WatanabeDepartment of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Masayuki AsanoDepartment of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Yoshihide AsanoDepartment of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

actionable genetic alterationsadvanced skin malignanciescomprehensive genomic profilingTMB

Identifiers

PMID41799786
PMCPMC12962143

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.